Spain’s health ministry has approved funding for Tofersen (Qalsody), the first EU-approved drug targeting a genetic cause of ALS—SOD1 mutations. This personalized therapy silences the gene...
The British scientist has made vast contributions in the fields of cosmology and theoretical physics.